115 related articles for article (PubMed ID: 7005627)
41. A low-molecular-weight, chromium-binding substance in mammals.
Yamamoto A; Wada O; Ono T
Toxicol Appl Pharmacol; 1981 Jul; 59(3):515-23. PubMed ID: 7268774
[No Abstract] [Full Text] [Related]
42. Severe hypertriglyceridaemia responding to insulin and nicotinic acid therapy.
Smith SR
Postgrad Med J; 1981 Aug; 57(670):511-5. PubMed ID: 7029504
[TBL] [Abstract][Full Text] [Related]
43. Chromium in metabolic and cardiovascular disease.
Hummel M; Standl E; Schnell O
Horm Metab Res; 2007 Oct; 39(10):743-51. PubMed ID: 17952838
[TBL] [Abstract][Full Text] [Related]
44. Biological activity of glucose tolerance factor in swine.
Steele NC; Althen TG; Frobish LT
J Anim Sci; 1977 Dec; 45(6):1341-5. PubMed ID: 606707
[No Abstract] [Full Text] [Related]
45. [Importance of essential macronutrients in the human organism: the role of chromium].
Mancinella A
Clin Ter; 1988 May; 125(4):295-301. PubMed ID: 2974366
[No Abstract] [Full Text] [Related]
46. Chromium (D-phenylalanine)3 improves obesity-induced cardiac contractile defect in ob/ob mice.
Dong F; Yang X; Sreejayan N; Ren J
Obesity (Silver Spring); 2007 Nov; 15(11):2699-711. PubMed ID: 18070761
[TBL] [Abstract][Full Text] [Related]
47. Chromium(III) and the glucose tolerance factor.
SCHWARZ K; MERTZ W
Arch Biochem Biophys; 1959 Nov; 85():292-5. PubMed ID: 14444068
[No Abstract] [Full Text] [Related]
48. PAR-5359, a well-balanced PPARalpha/gamma dual agonist, exhibits equivalent antidiabetic and hypolipidemic activities in vitro and in vivo.
Kim MK; Chae YN; Son MH; Kim SH; Kim JK; Moon HS; Park CS; Bae MH; Kim E; Han T; Choi HH; Shin YA; Ahn BN; Lee CH; Lim JI; Shin CY
Eur J Pharmacol; 2008 Oct; 595(1-3):119-25. PubMed ID: 18727927
[TBL] [Abstract][Full Text] [Related]
49. Failure of trivalent chromium to improve hyperglycemia in diabetes mellitus.
Sherman L; Glennon JA; Brech WJ; Klomberg GH; Gordon ES
Metabolism; 1968 May; 17(5):439-42. PubMed ID: 4869710
[No Abstract] [Full Text] [Related]
50. Effect of chromium nicotinic acid supplementation on selected cardiovascular disease risk factors.
Thomas VL; Gropper SS
Biol Trace Elem Res; 1996 Dec; 55(3):297-305. PubMed ID: 9096856
[TBL] [Abstract][Full Text] [Related]
51. Beneficial effect of chromium-rich yeast on glucose tolerance and blood lipids in elderly subjects.
Offenbacher EG; Pi-Sunyer FX
Diabetes; 1980 Nov; 29(11):919-25. PubMed ID: 7000589
[TBL] [Abstract][Full Text] [Related]
52. Hyperlipidaemia and cardiovascular disease: nonantilipolytic effects of nicotinic acid in adipose tissue.
Karpe F; Chamas L
Curr Opin Lipidol; 2010 Jun; 21(3):282-3. PubMed ID: 20463475
[No Abstract] [Full Text] [Related]
53. Effect of chromium supplementation on production and metabolic parameters in periparturient dairy cows.
Hayirli A; Bremmer DR; Bertics SJ; Socha MT; Grummer RR
J Dairy Sci; 2001 May; 84(5):1218-30. PubMed ID: 11384049
[TBL] [Abstract][Full Text] [Related]
54. Effects of SGLT2 selective inhibitor ipragliflozin on hyperglycemia, hyperlipidemia, hepatic steatosis, oxidative stress, inflammation, and obesity in type 2 diabetic mice.
Tahara A; Kurosaki E; Yokono M; Yamajuku D; Kihara R; Hayashizaki Y; Takasu T; Imamura M; Li Q; Tomiyama H; Kobayashi Y; Noda A; Sasamata M; Shibasaki M
Eur J Pharmacol; 2013 Sep; 715(1-3):246-55. PubMed ID: 23707905
[TBL] [Abstract][Full Text] [Related]
55. Synergistic Cardioprotective Effects of Combined Chromium Picolinate and Atorvastatin Treatment in Triton X-100-Induced Hyperlipidemia in Rats: Impact on Some Biochemical Markers.
Shafik NM; Baalash A; Ebeid AM
Biol Trace Elem Res; 2017 Dec; 180(2):255-264. PubMed ID: 28409410
[TBL] [Abstract][Full Text] [Related]
56. [The Supreme Court for insulin?].
Grimaldi A; Sepulveda-Lavados A
Ann Med Interne (Paris); 1993; 144(4):227-8. PubMed ID: 8368713
[No Abstract] [Full Text] [Related]
57. Dietary chromium tripicolinate supplementation reduces glucose concentrations and improves glucose tolerance in normal-weight cats.
Appleton DJ; Rand JS; Sunvold GD; Priest J
J Feline Med Surg; 2002 Mar; 4(1):13-25. PubMed ID: 11869052
[TBL] [Abstract][Full Text] [Related]
58. Chromium supplementation in impaired glucose tolerance of elderly: effects on blood glucose, plasma insulin, C-peptide and lipid levels.
Uusitupa MI; Mykkänen L; Siitonen O; Laakso M; Sarlund H; Kolehmainen P; Räsänen T; Kumpulainen J; Pyörälä K
Br J Nutr; 1992 Jul; 68(1):209-16. PubMed ID: 1390605
[TBL] [Abstract][Full Text] [Related]
59. The effects of the glycation of transferrin on chromium binding and the transport and distribution of chromium in vivo.
Deng G; Dyroff SL; Lockart M; Bowman MK; Vincent JB
J Inorg Biochem; 2016 Nov; 164():26-33. PubMed ID: 27592288
[TBL] [Abstract][Full Text] [Related]
60. [Vanadium compounds--a new class of therapeutic agents for the treatment of diabetes mellitus].
Beliaeva NF; Gorodetskiĭ VK; Tochilkin AI; Golubev MA; Semenova NV; Kovel'man IR
Vopr Med Khim; 2000; 46(4):344-60. PubMed ID: 11075417
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
